L. Czollner

Development of a Pilot Scale Process for the Anti-Alzheimer Drug (−)-Galanthamine Using Large-Scale Phenolic Oxidative Coupling and Crystallisation-Induced Chiral Conversion

B. Kuenburg, L. Czollner, Johannes Fröhlich et al. · Organic Process Research & Development · 1999 · 117 citations

Bioorganic Chemistry, Pharmaceutical Chemistry, Medicinal Chemistry +16

New kilogram-synthesis of the anti-alzheimer drug (−)-galanthamine

L. Czollner, Werner Frantsits, B. Kuenburg et al. · Tetrahedron Letters · 1998 · 67 citations

Medicinal Chemistry, New Kilogram-synthesis, Medicine +5

Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases

I. Beseda, L. Czollner, Priti Shah et al. · Bioorganic & Medicinal Chemistry · 2009 · 66 citations · Full text

Glycosylation, Biochemistry, Glycyrrhetinic Acid Derivatives +6

Synthesis of Pyrrolidine Analogues of <i>N</i>‐Acetylneuraminic Acid as Potential Sialidase Inhibitors

L. Czollner, János Kuszmann, Andrea Vasella · Helvetica Chimica Acta · 1990 · 32 citations

Biosynthesis, Bioorganic Chemistry, Antimicrobial Drug Discovery +15

1,2,4‐Triazoles, VI¹⁾: Synthesis of New 1,5‐Diphenyl‐3‐<i>H</i>‐1,2,4‐triazoles Substituted with H‐, Alkyl, or Carboxyl Groups at C‐3

L. Czollner, G. Szilágyi, József Langó et al. · Archiv der Pharmazie · 1990 · 31 citations